All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.
Jean-Jacques Kiladjian is a Professor of Clinical Pharmacology at Université Paris Cité, Paris, FR, and a Consultant Hematologist and Head of the Clinical Investigation Center of Hôpital Saint-Louis, Paris, FR. Professor Kiladjian’s work focuses on clinical research and the development of novel therapeutics for the treatment of patients with myeloproliferative neoplasms (MPN) and myelodysplastic syndromes.
Professor Kiladjian is an active member of many societies, including the European Hematology Association, for which he is co-chair of the Scientific Working Group on MPN. He is also a member of the American Society of Hematology, as well as the European LeukemiaNet, for which he is secretary of the MPN Working Group, and president of the French Intergroup of Myeloproliferative neoplasms.